These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Kuhn H; Gietzen FH; Leuner C; Schäfers M; Schober O; Strunk-Müller C; Obergassel L; Freick M; Gockel B; Lieder F; Raute-Kreinsen U Z Kardiol; 2000; 89 Suppl 4():IV41-54. PubMed ID: 10810776 [TBL] [Abstract][Full Text] [Related]
6. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis. Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430 [TBL] [Abstract][Full Text] [Related]
7. Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM). Schulte HD; Bircks W; Lösse B Z Kardiol; 1987; 76 Suppl 3():145-51. PubMed ID: 3433868 [TBL] [Abstract][Full Text] [Related]
8. Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy. Deb SJ; Schaff HV; Dearani JA; Nishimura RA; Ommen SR Ann Thorac Surg; 2004 Dec; 78(6):2118-22. PubMed ID: 15561048 [TBL] [Abstract][Full Text] [Related]
15. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. Ball W; Ivanov J; Rakowski H; Wigle ED; Linghorne M; Ralph-Edwards A; Williams WG; Schwartz L; Guttman A; Woo A J Am Coll Cardiol; 2011 Nov; 58(22):2313-21. PubMed ID: 22093509 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives. Ammirati E; Contri R; Coppini R; Cecchi F; Frigerio M; Olivotto I Eur J Heart Fail; 2016 Sep; 18(9):1106-18. PubMed ID: 27109894 [TBL] [Abstract][Full Text] [Related]
17. Advances in medical treatment of hypertrophic cardiomyopathy. Hamada M; Ikeda S; Shigematsu Y J Cardiol; 2014 Jul; 64(1):1-10. PubMed ID: 24735741 [TBL] [Abstract][Full Text] [Related]
18. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy]. Gao YC; Li Y; Han ZH; Zhang XL; Zhao H; Jiang TY Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):333-6. PubMed ID: 17711659 [TBL] [Abstract][Full Text] [Related]
19. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258 [TBL] [Abstract][Full Text] [Related]